Double Digit NASDAQ Stock Winners: SRZN, RNTX, BBIG
8:12 am Wednesday, September 08th, 2021
Following are major stock gainers on Nasdaq in Tuesday’s trading session:
Surrozen, Inc. (NASDAQ:SRZN) was the active stock gainer on Tuesday and soared 37% to $9.90. Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies to engage the body’s existing biological repair mechanisms with potential application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 that stimulates hepatocyte regeneration, improves liver function, and reduces fibrosis; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are highly expressed in intestinal crypts. The company was founded in 2016 and is headquartered in South San Francisco, California.
RenovoRx, Inc. (NASDAQ:RNXT) was another notable winner as the stock went up 26% to end the session at $9.95. The FDA has granted a new 510(k) clearance to RenovoRx Inc’s (NASDAQ: RNXT) RenovoCath Delivery System. The RenovoCath Delivery System is the device component of the Company’s initial product, RenovoGem.
The drug/device combination used in RenovoRx’s Trans-Arterial Micro-Perfusion (RenovoTAMP) therapy platform is a dual-balloon infusion catheter delivering chemotherapy directly to tumors via arteries. The new design provides more targeted therapy delivery, translating into more effective treatment with fewer side effects. RenovoRx received it’s initial 510(k) for the RenovoCath delivery system in 2014. RenovoRx is conducting a Phase 3 trial utilizing the RenovoTAMP platform to evaluate RenovoGem in pancreatic cancer. The study has reached 44% patient enrollment and is expected to involve approximately 200 participants.
Vinco Ventures, Inc. (NASDAQ:BBIG) moved up 21% to $9.66. Vinco Ventures, Inc. operates as a consumer product research and development, manufacturing, sales, and fulfillment company in North America, the Asia Pacific, and Europe. It offers toys, plush, homewares, and electronics to retailers, distributors, and manufacturers through e-commerce channels; and personal protective equipment to governmental agencies, hospitals, and distributors. The company was formerly known as Edison Nation, Inc. and changed its name to Vinco Ventures, Inc. in November 2020. Vinco Ventures, Inc. was incorporated in 2017 and is based in Bethlehem, Pennsylvania.
